Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunome Inc (NQ: IMNM )

4.980 +0.050 (+1.01%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,356
Open 4.940
Bid (Size) 4.600 (5)
Ask (Size) 7.600 (1)
Prev. Close 4.930
Today's Range 4.940 - 5.190
52wk Range 2.200 - 7.420
Shares Outstanding 12,215,018
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
From Immunome, Inc.
Via Business Wire
Immunome: Q1 Earnings Insights
 
Via Benzinga

Performance

YTD
+52.76%
+52.76%
1 Month
-13.54%
-13.54%
3 Month
+14.75%
+14.75%
6 Month
+17.73%
+17.73%
1 Year
+27.04%
+27.04%

More News

Read More
Immunome Reports First Quarter 2023 Financial Results
From Immunome, Inc.
Via Business Wire
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results
From Immunome, Inc.
Via Business Wire
Immunome Stock Jumps On Discovery Pact With AbbVie
Via Benzinga
Immunome's COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants
Via Benzinga
Short Volatility Alert: Immunome, Inc.
Via Benzinga
Immunome to Present at 13th Annual World ADC London Conference
From Immunome, Inc.
Via Business Wire
Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
From Immunome, Inc.
Via Business Wire
AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal
Via Investor's Business Daily
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
Via Benzinga
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
From Immunome, Inc.
Via Business Wire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Immunome Reports Third Quarter 2022 Financial Results
From Immunome, Inc.
Via Business Wire
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
From Immunome, Inc.
Via Business Wire
Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer
From Immunome, Inc.
Via Business Wire
Recap: Immunome Q2 Earnings
Via Benzinga
Immunome Reports Second Quarter 2022 Financial Results
From Immunome, Inc.
Via Business Wire
Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against the Most Prevalent Omicron Subvariants* in the US, BA.4/5 and BA.2.12.1
From Immunome, Inc.
Via Business Wire
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Jefferies Healthcare Conference
From Immunome, Inc.
Via Business Wire
Immunome Provides Research & Development Update on Lead Oncology Candidate Targeting IL-38
From Immunome, Inc.
Via Business Wire
71 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.